High Blood Pressure

High Blood Pressure Hypertension

Hypertension or high blood pressure is known as the "silent killer" because despite being one of the most common fatal conditions worldwide, most people are unaware they have the condition because it presents with very few or no symptoms.

What Causes High Blood Pressure?

Hypertension Symptoms and Effects

Hypertension Diagnosis

Hypertension Treatment

Anti-Hypertensive Drugs

High Blood Pressure in Children

Link between Bisphenol A and Increase in Blood Pressure

Hypertension Risk Factors

Ambulatory Blood Pressure Monitoring

Are Blood Pressure Monitors Accurate?

What is Obesity?

See more featured articles »

Causes of Obesity and Overweight

Obesity, What Can be Done?

What is Body Mass Index (BMI)?

Obesity and Fast Food

Obesity and Exercise

Obesity Management

Obesity and Blood Pressure

Obesity and Metabolic Syndrome

Obesity Epidemiology

What is Obesity Paradox?

Obesity and Periodontitis

Obesity in Children

Obesity and Respiratory Disorders

Obesity and Heart Disease

Obesity and Anesthesia

Obesity and Skin Problems

Fat Mass and Obesity-Associated Gene (FTO)

What does Sleeve Gastrectomy Involve?

Dieting for Obese Children

Abdominal Obesity and the Metabolic Syndrome

DASH Diet for High Blood Pressure

Solitary Kidney and High Blood Pressure Monitoring

Causes of angina

Risk Factors for Atherosclerosis

High Cholesterol and Stroke Risk

Latest High Blood Pressure News and Research

Study identifies 17 modifiable risk factors shared between stroke, dementia, and depression

Age-related brain diseases such as stroke, dementia, and late-life depression are a debilitating part of growing older, but people can lower their risk of these diseases through behavioral and lifestyle changes.

3 Apr 2025

Rutgers researchers develop promising new oral antiviral for COVID-19

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

3 Apr 2025

Heart failure linked to faster cognitive decline

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests.

3 Apr 2025

Blood pressure trajectories during early pregnancy can stratify future hypertension risk

NIH-supported study reveals new risk group for future high blood pressure, heart disease.

2 Apr 2025

Football proven to prevent and treat lifestyle diseases

Danish researchers, in collaboration with the Danish Football Association, have released a White Paper that describes football as an effective recipe in the prevention and treatment of lifestyle-related diseases.

2 Apr 2025

Rural communities face higher rates of heart disease and risk factors

A research team funded by the National Institutes of Health (NIH) uncovered higher rates of heart disease and worse heart health affecting adults living in rural communities compared to urban areas and the factors that likely drive these differences.

1 Apr 2025

Gastric bypass proven most effective for severe obesity in landmark study

Gastric bypass is the most clinically and cost effective form of interventional surgery for people living with severe obesity, reveals landmark research funded and supported by the National Institute for Health and Care Research (NIHR).

1 Apr 2025

Study finds clues to hypertension hidden in electronic health records

A new study from investigators at Mass General Brigham shows that clues about hypertension may be buried in electronic health records (EHR).

1 Apr 2025

Five lifestyle changes by 50 can add a decade to your life, global study finds

Study estimates the global lifetime risk and benefits of modifying cardiovascular risk factors like hypertension, smoking, and obesity by age 50, showing significant improvements in both life expectancy and quality of life. It highlights the importance of early intervention and midlife changes in preventing cardiovascular disease and mortality.

31 Mar 2025

$Intravenous iron shows promise for heart failure with reduced ejection fraction$

Intravenous iron shows promise for heart failure with reduced ejection fraction

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

31 Mar 2025

AI-based imaging performs equally well as ultrasound in guiding heart procedures

Patients with narrowing of at least 50% in three major coronary arteries did equally well when treated with a minimally invasive stent placement guided either by ultrasound-based imaging or by a novel, artificial-intelligence-powered (AI), non-invasive imaging technique derived from angiography, researchers reported at the American College of Cardiology's Annual Scientific Session (ACC.25).

31 Mar 2025

Investigational drug lorundrostat offers significant blood pressure drop compared with placebo

Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood pressure at 12 weeks compared with placebo, according to a study presented at the American College of Cardiology's Annual Scientific Session.

31 Mar 2025

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.

31 Mar 2025

WARRIOR trial finds no impact of intensive therapy on heart events in women

An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years in women who experienced signs and symptoms of ischemia, or insufficient blood flow to the heart muscle, but had no blockages in their heart's arteries, according to research presented at the American College of Cardiology's Annual Scientific Session.

29 Mar 2025

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Simultaneous screening for hypertension and arrhythmia could prevent strokes

A group of 29 international experts says that simultaneous screening for hypertension and heart arrhythmia could prevent thousands of strokes.

27 Mar 2025

Older Americans support insurance coverage for obesity medications

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.

27 Mar 2025

High blood pressure can lead to structural changes in the kidneys

A research team from the Medical University of Vienna has investigated structural changes in kidneys of patients with hypertension and type 2 diabetes.

27 Mar 2025

Conversations on AFM: Exploring the nanomechanics of living cells

In this interview Prof. Dr. Kristina Kusche-Vihrog speaks about the nanomechanics of living cells and their implications for cardiovascular disease.

From Bruker BioAFM 27 Mar 2025

Addressing cardiovascular risk factors in emerging adulthood

Many teenagers enter adulthood with significant risk factors for cardiovascular disease, and the transition from adolescence to adulthood is a key time to address these risk factors and reduce the risk of developing future cardiovascular disease, according to a new American Heart Association scientific statement published today in the Journal of the American Heart Association.

26 Mar 2025